Medical Devices Industry News

 The International Agency for Research on Cancer (IARC) states that “In 2018 there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide”. The organization also forecasts that by 2040, cancer will account for nearly 16.3 million deaths globally. Moreover, the World Health Organization (WHO) estimates that 2.26 million, 2.21 million, and 1.93 million new cases of breast cancer, lung cancer, and colon and rectum cancer were diagnosed in 2020. Additionally, the number of prostate, skin (non-melanoma), and stomach cancer cases is rising at an exponential rate. The increasing cancer burden is encouraging healthcare companies and government organizations to work toward providing better diagnostic facilities, owing to which the aspiration and biopsy needles market will march at a CAGR of 7.2% during 2020–2030. The market was valued at $801.5 million in 2019, and it is expected to generate $1,717.9 million revenue by 2030. Biopsy and aspiration are performed to study t...

 In 2021, the global brain modalities and software market was valued at $13,343.3 million, which is set to reach $23,195.6 million by 2030, at a CAGR of 5.2% during 2021–2030.    Because traditional methods combined with AI software produce faster and more-reliable results, they are gaining favor. However, although software solutions provide value to standalone imaging modalities, in terms of numerical evaluations, diagnostic accuracy, and precision, software adoption in the LATAM and MEA regions has been slow, which will impel brain modalities and software market players to aggressively market their offerings here. Key Findings of Brain Modalitiesand Software Market Report •                       APAC is a rapidly growing brain modalities and software market, with a CAGR of roughly 7% predicted over the projection period. The increasing healthcare spending,...

 The demand for point of care testing (POCT) is increasing across the globe because of the growing aging population, rising prevalence of chronic diseases, and lifestyle changes. POCT is the performance of a test nearby to the site of the patient care for providing immediate results outside the traditional laboratory environment. In addition to this, diagnostic companies, such as Alere, Abaxis, and Cepheid, have started recognizing the potential of quick molecular diagnostic testing, which why they have launched various point of care products that are based on microfluidic technology in the past few years. This, in turn, is expected to drive the requirement for microfluidic devices.  Browse detailed report on Microfluidic Devices Market Size, and Business Outlook Microfluidic devices are gaining traction because they have the ability to perform several of the current large-scale applications at a smaller scale, due to which instrument size and sample consumption can be reduced...

The World Health Organization (WHO) estimates that approximately 17.9 million human lives were lost due to cardiovascular diseases (CVDs) in 2019. Of these deaths, nearly 85% were caused due to heart attacks and strokes. The WHO also reports that nearly 236,000 fatalities occurred due to drowning in 2019. Furthermore, the Centers for Disease Control and Prevention (CDC) states that sickle cell disease (SCD) affects around 100,000 Americans each year. The CDC also estimates that around 1 in 13 African-American babies is born with the sickle cell trait (SCT). Get More details Pulse Oximeter Market Trends and Opportunities The surging incidence of heart attacks, SCD, and drownings will help the pulse oximeter market advance at a CAGR of 8.3% during 2019–2024. According to P&S Intelligence, the market revenue is projected to rise from $1,979.0 million in 2018 to $3,177.7 million by 2024. Additionally, the rising prevalence of multisystem trauma and apneic conditions will create a huge ...

Minimally invasive surgeries (MISs) involve minimal surgical incisions and are aimed at reducing trauma to the body. These are most commonly performed with the help of electrosurgical instruments, inflation systems, handheld instruments, and guiding devices. Sutures, forceps, graspers, spatulas, retractors, and dilators are the types of handheld devices that find application in virtually all types of MISs. The minimally invasive surgical instruments market is being positively impacted by the growing geriatric population. Owing to their weakened immune system and diminished physical strength, the elderly are more susceptible to various diseases that require surgical intervention. The major causes of the growing elderly population are falling birth rates and increasing life expectancy. A United Nations Department of Economic and Social Affairs report mentioned that the number of people over 60 years and above is going to grow to 1.4 billion by 2030, globally. Similarly, the surging prev...

 The rising incidence of degenerative disc diseases is fueling the demand for artificial discs across the world. According to the observations of the National Center for Biotechnology Information (NCBI), which is a branch of the U.S. government’s National Institutes of Health, 266 million people around the world are diagnosed with lumbar degenerative disc disease every year, with Europe recording the highest incidence of the disease (5668 people out of every 100,000 individuals).  Apart from the growing prevalence of the degenerative disc disease, the soaring geriatric population is also positively impacting the worldwide demand for artificial discs. According to the 2020 World Population Ageing report published by the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65 years or above all over the world will rise from 727 million in 2020 to more than 1.5 billion by 2050. As geriatric people are highly vulnerable to the degenerati...

Wounds, in which the epidermis is torn apart and the deeper layers of the dermis are exposed, are one of the most-easily recognizable signs of a physical injury. Wounds can range from a simple skin abrasion to those that end up exposing the bone! Apart from injuries, wounds can be a result of surgeries and also certain diseases. The severe wounds, if not closed off in time, can lead to excessive blood loss and, ultimately, death. Therefore, due to the increasing awareness about the dangers of unhealed wounds, P&S Intelligence says that the wound care biologics market will grow from $1.4 billion in 2018 to $2.0 billion by 2024, at a 7.0% CAGR during 2019–2024. With advancements in the healthcare sector, traditional wound care products, such as gauze, are being replaced with biologics, which are agents synthesized from living organisms. Growth factors, skin substitutes, and an array of cell-based, collagen-based, and enzyme-based biologics are now available for wound care. Among thes...